In contrast, the scores of patients in the trial increased an average of 1.2 points per year, a difference that is statistically significant. (sciencedaily.com)
A patient may belong to a defined target population but still not respond to a treatment the way the «average» patient in a trial did. (sciencenews.org)
Based on the findings in this study, the team is now considering the possibility of adding mitochondrial inhibitors into the therapeutic mix for patients in this trial. (newsroom.cumc.columbia.edu)